Global Financial Private Capital’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,157
Closed -$233K 362
2018
Q3
$233K Sell
2,157
-2,521
-54% -$277K 0.01% 483
2018
Q2
$514K Sell
4,678
-64
-1% -$6.67K 0.02% 363
2018
Q1
$476K Sell
4,742
-1,257
-21% -$129K 0.02% 357
2017
Q4
$591K Buy
5,999
+146
+2% +$13.8K 0.02% 319
2017
Q3
$548K Buy
5,853
+643
+12% +$68.3K 0.02% 315
2017
Q2
$579K Buy
5,210
+391
+8% +$41.3K 0.03% 165
2017
Q1
$473K Buy
+4,819
New +$459K 0.02% 172

Other funds holding DGX

Global Financial Private Capital's DGX Position: Q4 2018 in Review

Global Financial Private Capital sold out of Quest Diagnostics (DGX) in Q4 2018, closing a stake of 2,157 shares — an estimated $233K sold.

Global Financial Private Capital first reported a position in DGX in Q1 2017 and held it in 7 quarters. The position peaked at $591K in Q4 2017. 624 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

  • Global Financial Private Capital reported no remaining Quest Diagnostics position as of Q4 2018 after selling out during the quarter.
  • Global Financial Private Capital sold 2,157 Quest Diagnostics shares in Q4 2018, an estimated $233K.
  • Global Financial Private Capital first reported a position in Quest Diagnostics in Q1 2017 and held it in 7 quarters.
  • Global Financial Private Capital's Quest Diagnostics position peaked at $591K in Q4 2017.
  • 624 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on Global Financial Private Capital's 13F filing for Q4 2018, filed 5 Feb 2019.